CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Dermagnostix has developed a rapid, automated diagnostic platform for skin diseases, enabling objective molecular testing that can identify up to 40 targets in just 90 minutes. This technology aims to reduce misdiagnoses and improve patient care in dermatology.
At Dermagnostix, we envision the next level for molecular diagnostics in human skin to improve patients’ lives and clinical practice in dermatology.Skin diseases are the 4th most relevant human illnesses according to loss of quality of life.
Conventional diagnostics in dermatology based on clinical view and histopathology are imprecise and subjective, resulting in up to 50% of misdiagnosed cases and insufficient or harmful therapies.
At Dermagnostix, we have developed a comprehensive technologic…
DERMAGNOSTIX GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
